-
-
-
-
-
-
-
Immunovant, Inc. (IMVT) Misses Q4 EPS by 13c
-
-
-
-
-
-
-
Bernstein SocGen Group Starts Roivant Sciences (ROIV) at Outperform
-
-
-
-
-
-
-
Immunovant, Inc. (IMVT) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Immunovant (IMVT)
-
-
-
-
-
-
-
Citi Reiterates Buy Rating on Immunovant (IMVT)
-
-
-
-
-
-
-
Immunovant (IMVT) Announces $450 Million Private Placement
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Immunovant (IMVT)
-
456,424 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

